Navigation Links
Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
Date:6/4/2008

s; risks relating to the ability of our development partners and third-party suppliers of materials, drug substance and related components to provide us with adequate supplies and expertise to support manufacture of drug product for initiation and completion of our clinical studies; risks relating to the transfer of our manufacturing technology to third-party contract manufacturers, and the risk that recurring losses, negative cash flows and the inability to raise additional capital could threaten our ability to continue as a going concern.

Pharmaceutical and biotechnology companies have suffered significant setbacks in advanced clinical trials, even after obtaining promising results from earlier preclinical or clinical studies. Data obtained from such studies are susceptible to varying interpretations, which could delay, limit or prevent regulatory approval. Except to the extent required by applicable laws or rules, we do not undertake to update any forward-looking statements or to publicly announce revisions to any of our forward-looking statements, whether resulting from new information, future events or otherwise.


'/>"/>
SOURCE Arno Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
2. Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
3. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
4. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
5. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
6. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
9. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
10. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
11. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Calif. , July 28, 2015 /PRNewswire-USNewswire/ -- ... prescription drug abuse and doctor shopping after a 2012 ... prescribing powerful and addictive medications is yet more evidence ... today. Since Kentucky,s ... of patients "doctor shopping" declined by 52 percent; opioid ...
(Date:7/28/2015)... DUBLIN , July 21, 2015 ... ) has announced the addition of the ... Share, Growth, Trends and Forecast 2014 - 2022" ... report on the craniomaxillofacial implants market studies the ... Craniomaxillofacial implants are rapidly gaining popularity in the ...
(Date:7/28/2015)... July 28, 2015 According to ... by Type (Dermatology Treatment Devices, and Dermatology Diagnostic Devices ... Application, by Geography - Analysis and Forecast to 2019", ... $11.88 billion by 2019, at a CAGR of 10.4% ... TOC of Global Dermatology Devices Market for an in-depth ...
Breaking Medicine Technology:Study Shows Requiring Prescription Drug Database Use Before Prescribing Powerful, Addictive Medications Critical In Ending Growing Epidemic, says Consumer Watchdog 2Global Craniomaxillofacial Implants (Plate and Screw Fixator Systems, Bone Graft Substitutes, Distraction Systems, and TMJ Replacement Devices) Market Analysis 2014-2022 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 3
... Dec. 5, 2011 Tengion, Inc. (Nasdaq: TNGN ... of John L. Miclot as its President and Chief Executive ... Pincus.  He was President and Chief Executive Officer of CCS ... provider of products and services for patients with chronic diseases, ...
... 2011 The National Foundation for Infectious Diseases (NFID) ... in highlighting the importance of influenza prevention during National ... encouraging vaccination through the holiday season and beyond. ... over the past few years, but many parents remain ...
Cached Medicine Technology:Tengion Appoints John L. Miclot President and Chief Executive Officer 2Tengion Appoints John L. Miclot President and Chief Executive Officer 3Tengion Appoints John L. Miclot President and Chief Executive Officer 4National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 2National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 3National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 4
(Date:7/29/2015)... , ... July 29, 2015 , ... Attorneys representing American ... Powder Cancer Lawsuit Center. The website now features a page dedicated to news related ... from other sources. The Talcum Powder Lawsuit News page was launched with ...
(Date:7/29/2015)... ... ... mybody ” was featured on NewsWatch as part of its monthly Biz Report, which ... industry. Andrew Tropeano, the host of NewsWatch and business expert, conducted the business review ... the skin’s defense system from the inside out. , According to Statista, the global ...
(Date:7/29/2015)... ... July 29, 2015 , ... People that are passionate about gardening ... on Mercola.com: a vertical “garden tower” and enhanced mineral product for growing ideal crops. ... corners on a porch, balcony, or rooftop – can hold up to 100 plants ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... board-certified gastroenterologist, has launched a chewable version of its EndoMune Jr. probiotic supplement ... a tasty, all-natural supplement that children can enjoy to maintain a healthy balance ...
(Date:7/29/2015)... ... , ... Nature’s Artisan, a new holistic oral care company, has released a ... founded by Tina Yarandi, who came up with the idea for the product line ... amazed when she learned about the incredible dental benefits of xylitol, but was disappointed ...
Breaking Medicine News(10 mins):Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2
... Data Show Activity in First- and Late-Line Treatment of ... EXEL ),reported data from three clinical trials of ... VEGFR2, at the 44th Annual Meeting of the,American Society ... 2 trial in previously untreated, clinically selected non-small cell,lung ...
... Colo., June 2 Baxa Corporation announces the,launch ... Academics and,Resources (STAR) Center in Englewood, Colorado. The ... the expanding course offerings,at the Baxa facility. Currently, ... state-of-the-art cleanroom training facility. Baxa expects,to continue adding ...
... June 2 American Oriental,Bioengineering (NYSE: AOB ... has,authorized a share repurchase program for the repurchase ... common stock., Purchases under this program may ... market, privately negotiated transactions, and accelerated stock,repurchase transactions ...
... product development and clinical evaluation activities, ... Inc., a privately,held company developing and commercializing ... life science, biodefense, environmental,testing, point-of-care diagnostics and ... been awarded a $996,000 contract by the ...
... ... WHO: Valley Forge Medical Center & Hospital, WHERE: ... ... Forge Medical Center and,Hospital is the first facility on the East Coast to obtain the,Addiction-Free Pain ...
... TraderNotes on stocks that are making news today., ... for free by visiting:, http://www.BeaconEquity.com/m , Today,s TraderNotes ... (Nasdaq: RXII ), Vion Pharmaceuticals Inc.,(Nasdaq: VION ... (Nasdaq: AMGN ),Gilead Sciences Inc. (Nasdaq: GILD ...
Cached Medicine News:Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 2Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 3Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 4Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 5Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 6Health News:Baxa Launches New Microsite for STAR Center Training Facility 2Health News:American Oriental Bioengineering Announces US$75 Million Share Repurchase Program 2Health News:Cantimer, Inc. Awarded $996,000 Contract from U.S. Government to Develop Portable, Real-Time and Non-Invasive Hydration Measurement and Monitoring System for Use by Firefighters 2Health News:Valley Forge Medical Center and Hospital to Become the First Addiction-Free Pain Management Center of Excellence on the East Coast; Will Host Three Day Professional Training Seminar. 2Health News:Valley Forge Medical Center and Hospital to Become the First Addiction-Free Pain Management Center of Excellence on the East Coast; Will Host Three Day Professional Training Seminar. 3Health News:BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR 2Health News:BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: